Soluble Collagen VI treatment enhances mesenchymal stem cells expansion for engineering cartilage

Bone Marrow‐derived mesenchymal stem cells (BM‐MSC) are an attractive source for cell‐based therapies in cartilage injury owing to their efficient differentiation into chondrocytes and their immune‐suppressive abilities. However, their clinical use is hampered by a scarcity of cells leading to compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeriglio, Piera, Lee, Jieun, Bhutani, Nidhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689496/
https://www.ncbi.nlm.nih.gov/pubmed/29313037
http://dx.doi.org/10.1002/btm2.10078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689496/
https://www.ncbi.nlm.nih.gov/pubmed/29313037
http://dx.doi.org/10.1002/btm2.10078

Ejemplares similares